期刊
CELL REPORTS
卷 12, 期 11, 页码 1887-1901出版社
CELL PRESS
DOI: 10.1016/j.celrep.2015.08.028
关键词
-
类别
资金
- NAIST Global COE Program (Frontier biosciences: strategies for survival and adaptation in a changing global environment)
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- NCNP [24-12]
- [24240051]
- Grants-in-Aid for Scientific Research [24390270, 26115716, 26830074] Funding Source: KAKEN
Rett syndrome (RTT) is a neurodevelopmental disorder caused by MECP2 mutations. Although emerging evidence suggests that MeCP2 deficiency is associated with dysregulation of mechanistic target of rapamycin (mTOR), which functions as a hub for various signaling pathways, the mechanism underlying this association and the molecular pathophysiology of RTT remain elusive. We show here that MeCP2 promotes the posttranscriptional processing of particular microRNAs (miRNAs) as a component of the microprocessor Drosha complex. Among the MeCP2-regulated miRNAs, we found that miR-199a positively controls mTOR signaling by targeting inhibitors for mTOR signaling. miR-199a and its targets have opposite effects on mTOR activity, ameliorating and inducing RTT neuronal phenotypes, respectively. Furthermore, genetic deletion of miR-199a- 2 led to a reduction of mTOR activity in the brain and recapitulated numerous RTT phenotypes in mice. Together, these findings establish miR-199a as a critical downstream target of MeCP2 in RTT pathogenesis by linking MeCP2 with mTOR signaling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据